该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 内部交易: 2016-03-16,总裁 & CEO,KLOSK STEVEN M ,卖出,19565普通股, $41.00
$凯姆布雷克斯(CBM)$ 内部交易: 2016-03-16,总裁 & CEO,KLOSK STEVEN M ,期权,19565普通股, $4.38
$凯姆布雷克斯(CBM)$ 内部交易: 2016-03-15,Director,Grabowsky Louis J. ,买入,750普通股, $40.10
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2016-03-16 AccNo: 0001437749-16-027763 Size: 33 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial S...
$凯姆布雷克斯(CBM)$ 内部交易: 2016-03-10,Director,KORB WILLIAM B ,卖出,4000普通股, $40.73
$凯姆布雷克斯(CBM)$ 内部交易: 2016-03-08,Director,KORB WILLIAM B ,卖出,4000普通股, $42.02
$凯姆布雷克斯(CBM)$ 内部交易: 2016-02-11,执行副总裁 & CFO,SARGEN GREGORY ,卖出,13622普通股, $36.16
$凯姆布雷克斯(CBM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001144204-16-080074 Size: 54 KB 网页链接
$凯姆布雷克斯(CBM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-10 AccNo: 0000932471-16-011317 Size: 39 KB 网页链接
$凯姆布雷克斯(CBM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001258897-16-002655 Size: 52 KB 网页链接